Functional study of gene hp0169 in Helicobacter pylori pathogenesis

Huilin Zhao1, Xiaofei Ji1, Xingxing Chen1

  • 1School of Basic Medical Sciences, Binzhou Medical University, Yantai 264003, China.

Microbial Pathogenesis
|January 30, 2017
PubMed

Insights

Helicobacter pylori gene hp0169, encoding collagenase HpPrtC, aids bacterial colonization by degrading collagen. The study reveals HpPrtC also influences host cell viability via an additional pathway, deepening understanding of H. pylori pathogenesis.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pathogenesis

Background:

  • Helicobacter pylori pathogenesis involves multiple virulence genes with unclear mechanisms.
  • Understanding these mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of gene hp0169, encoding putative collagenase HpPrtC, in H. pylori pathogenesis.
  • To elucidate the specific functions of HpPrtC in bacterium-host interactions.

Main Methods:

  • Recombinant HpPrtC activity assay on collagens.
  • Deletion of hp0169 via homologous recombination in H. pylori.
  • Assessment of host cell (GES-1) apoptosis, viability, and proliferation after infection with wild-type and mutant strains.

Main Results:

  • Recombinant HpPrtC demonstrated collagenolytic activity against native and heat-denatured collagens, suggesting a role in colonization.
  • The hp0169 mutant did not significantly alter GES-1 cell apoptosis induction.
  • GES-1 cells infected with the hp0169 mutant showed higher viability and proliferation rates compared to wild-type infection.

Conclusions:

  • HpPrtC functions as a virulence factor in H. pylori by degrading collagens, facilitating gastric colonization.
  • HpPrtC participates in H. pylori pathogenesis through collagen degradation and an additional, yet uncharacterized, pathway affecting host cell viability and proliferation.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.7K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
730
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.4K
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.4K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.4K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.6K